Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season

During the 2003-04 influenza season, 17 cases of Staphylococcus aureus community-acquired pneumonia (CAP) were reported from 9 states; 15 (88%) were associated with methicillin-resistant S. aureus (MRSA). The median age of patients was 21 years; 5 (29%) had underlying diseases, and 4 (24%) had risk...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Emerging infectious diseases 2006-06, Vol.12 (6), p.894-899
Hauptverfasser: Hageman, Jeffrey C, Uyeki, Timothy M, Francis, John S, Jernigan, Daniel B, Wheeler, J Gary, Bridges, Carolyn B, Barenkamp, Stephen J, Sievert, Dawn M, Srinivasan, Arjun, Doherty, Meg C, McDougal, Linda K, Killgore, George E, Lopatin, Uri A, Coffman, Rebecca, MacDonald, J Kathryn, McAllister, Sigrid K, Fosheim, Gregory E, Patel, Jean B, McDonald, L Clifford
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:During the 2003-04 influenza season, 17 cases of Staphylococcus aureus community-acquired pneumonia (CAP) were reported from 9 states; 15 (88%) were associated with methicillin-resistant S. aureus (MRSA). The median age of patients was 21 years; 5 (29%) had underlying diseases, and 4 (24%) had risk factors for MRSA. Twelve (71%) had laboratory evidence of influenza virus infection. All but 1 patient, who died on arrival, were hospitalized. Death occurred in 5 (4 with MRSA). S. aureus isolates were available from 13 (76%) patients (11 MRSA). Toxin genes were detected in all isolates; 11 (85%) had only genes for Panton-Valentine leukocidin. All isolates had community-associated pulsed-field gel electrophoresis patterns; all MRSA isolates had the staphylococcal cassette chromosome mec type IVa. In communities with a high prevalence of MRSA, empiric therapy of severe CAP during periods of high influenza activity should include consideration for MRSA.
ISSN:1080-6040
1080-6059
DOI:10.3201/eid1206.051141